Pharma News

Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.

BeiGene Announces Health Canada Approval for BRUKINSA® (zanubrutinib) in Relapsed or Refractory Marginal Zone Lymphoma

Friday, March 04, 2022

BeiGene a global sciencedriven biotechnology company focused on developing innovative and affordable medicines today announced that BRUKINSA zanubrutinib has been approved by Health Canada for the treatment of adult patients with marginal zone lympho...

Newomics and Bruker Announce Collaborations on High-throughput Bioanalysis

Thursday, March 03, 2022

Newomics Inc a biotechnology company commercializing mass spectrometry solutions for molecular detection and Bruker Corporation with differentiated highvalue life science research and diagnostics solutions today announced collaborations on a novel LC...

GC Labs and Two Clinical Diagnostic Companies Enter the Collaboration for the New Lab Testing Service

Thursday, March 03, 2022

GC Labs CEO Dr Eunhee Lee the leading clinical diagnostics company in Korea today announced the new lab testing service agreement with two partners Bio Lab in Bahrain and Biotrust in Cambodia Since the start of year GC Labs has actively established...

Ray Therapeutics and Forge Biologics Announce Viral Vector Contract Development and cGMP Manufacturing Partnership

Wednesday, March 02, 2022

Ray Therapeutics a biotechnology company developing optogenetic gene therapies for patients with retinal degenerative conditions and Forge Biologics a gene therapyfocused contract development and manufacturing organization announced a manufacturing p...

Amneal Enters U.S. Biosimilars Market With Approval of RELEUKOTM (filgrastim-ayow)

Wednesday, March 02, 2022

Amneal Pharmaceuticals Inc announced the US Food and Drug Administration FDA approval of the Biologics License Application BLA for filgrastimayow a biosimilar referencing Neupogen The product will be marketed under the proprietary name RELEUKOTM RELE...

Actym Therapeutics and Wacker Biotech Sign Manufacturing Contract for Actym's Lead Candidate for the Treatment of Solid Tumors

Tuesday, March 01, 2022

Actym Therapeutics a biotechnology company focused on the discovery and development of novel therapies intended to transform the treatment of cancer and Wacker Biotech announced today that they have signed a contract for the manufacturing of Actyms l...

Edenbridge Pharmaceuticals Announces the Launch of DARTISLA ODT

Tuesday, March 01, 2022

Edenbridge Pharmaceuticals LLC announced that DARTISLA ODT glycopyrrolate is now available by prescription in the United States through Phil the commercialization partner and eHub for DARTISLA ODT as well as in retail pharmacies throughout the countr...

Virios Therapeutics Announces Research Collaboration Exploring the Potential of Combination Antiviral Therapy for Treating Long COVID

Monday, February 28, 2022

Virios Therapeutics Inc a developmentstage biotechnology company focused on advancing novel antiviral therapies to treat chronic diseases including fibromyalgia announced today a collaboration with the Bateman Horne Center BHC of Salt Lake City Utah...

Taro Completes Acquisition of Alchemee

Monday, February 28, 2022

Taro Pharmaceutical Industries Ltd today announced the completion of its acquisition of Alchemee formerly The Proactiv Company TPC from Galderma The acquisition includes Alchemees business and assets worldwide including the Proactiv brand This acquis...

GliaPharm SA and the Wyss Center Enter Collaboration to Develop New Therapies for Alzheimer’s Disease

Friday, February 25, 2022

GliaPharm SA a biotech company that specializes in the research and development of novel therapies to treat and prevent neurological diseases and the Wyss Center a nonprofit organization dedicated to accelerating discoveries in neuroscience to improv...